Developer docs
API playgroundTry for free, no card

Search company profiles

etectRx

Full company profile

uuid000jh5m

Namestring
etectRx
Legal namestring
etectRx LLC
Websiteurl
etectrx.com
Company typeenum
Private
Founded yearint
2009
Descriptiontext

etectRx is a privately held digital health company headquartered in Alachua, Florida, founded in 2009. It commercializes the proprietary eBurst wireless sensor platform, which enables battery-free, disposable, ingestible, implantable, and wearable sensors for real-time remote health monitoring. The company sells two product systems built on this platform: the FDA-cleared ID-Cap System, an ingestible sensor capsule that transmits ingestion events to a wearable reader (necklace or wrist-worn) and onward to a clinician dashboard for medication adherence monitoring; and the eBrief System, a disposable battery-free moisture sensor insert that pairs with fixed room readers and a care dashboard to alert caregivers of urinary incontinence events in real time. The ID-Cap System is deployed primarily through clinical research partnerships with academic medical centers (University of Colorado, Mass General Brigham, UCLA, University of Cape Town) and pharmaceutical collaborators (Gilead, Pear Therapeutics), with applications in HIV, PrEP, hepatitis C, oncology, and CNS adherence studies.

The eBrief System is sold on a subscription license basis to senior living, assisted living, memory care, and skilled nursing facilities via a structured Early Adopter Program, with sequential pilots at operators including Trilogy Health Services, Mission Health Communities, EdenHill Communities, Mozaic, Black Hills Works, and The Village at Gainesville. Revenue is generated through eBrief subscription contracts (multi-year), ID-Cap hardware and digital pill sales, and clinical research study participation. The company holds 15 issued US patents, maintains HIPAA compliance, and has produced 15+ IRB-validated clinical studies including the NIH-sponsored QUANTI-TAF HIV adherence study demonstrating 95% cumulative adherence across 84 participants over four months.

Short descriptiontext

etectRx is a digital health company that commercializes its proprietary eBurst wireless sensor platform through two systems: the FDA-cleared ID-Cap ingestible sensor for medication adherence monitoring in clinical trials, and the eBrief disposable moisture sensor system for real-time incontinence care in senior living and long-term care facilities.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersGainesville, United States
HQ citystring
Gainesville
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
digital health sensors, medication adherence monitoring, ingestible sensor technology, remote patient monitoring, incontinence care systems
Industry3 codes
PRIMARYHLACAPAH
Medication Adherence & Smart Drug Delivery (Connected Inhalers, Pens, Pill Dispensers)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLACAPAB
Connected Medical Devices & Wearables (Sensors, Patches, Implantables)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHSABAJAI
Smart Home & Assistive Technology Installation for Aging-in-Place
Home & Personal Services/Elder Care & In-Home Care Services/Home Safety Assessment & Aging-in-Place Modifications
NAICS code1 code
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code1 code
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Digital Health Sensors & Remote Patient Monitoring
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1eBrief System Subscription
TypeSubscription Recurring
Description

The eBrief Intelligent Incontinence Monitoring System is offered through subscription license for senior living, assisted living, memory care, skilled nursing, and related healthcare facilities. The system includes sensors (disposable inserts), readers (fixed devices), monitoring tablets, and dashboard access.

etectrx.com
2ID-Cap System (Digital Pills)
TypeHardware Sales
Description

The FDA-cleared ID-Cap System generates revenue through the sale of digital pills (ingestible sensors), wearable readers, patient apps, and clinician dashboards. Revenue derived from clinical trials, healthcare providers, and pharmaceutical partnerships.

etectrx.com
3Clinical Research Partnerships
TypeProfessional Services
Description

Collaborations with academic medical centers, hospitals, and research institutions for medication adherence studies using the ID-Cap System. These partnerships support clinical validation and generate revenue through study participation.

straitsresearch.com
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations
Pricing details1 tier
1eBrief System subscription for healthcare facilities
ModelSubscriptionBilling cadenceMulti-year contract
Notes

The eBrief System is offered through subscription license to senior living, assisted living, memory care, skilled nursing facilities, and related healthcare organizations. Specific pricing tiers are not publicly disclosed.

etectrx.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 3 records shown
1eBurst
Description

Novel wireless sensor technology platform enabling real-time remote monitoring for ingestible, implantable, and wearable sensors.

etectrx.com
+2 more records
Core offering1 text field

etectRx develops and commercializes digital health monitoring systems based on its proprietary eBurst wireless sensor technology. Its primary offerings are the FDA-cleared ID-Cap System for medication adherence (ingestible sensor + wearable reader + apps + clinician dashboard) and the eBrief Intelligent Incontinence Monitoring System (disposable battery-free moisture sensors + room readers + care dashboard) sold to senior living, assisted living, and long-term care facilities.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 95% cumulative adherence rate in QUANTI-TAF HIV treatment study with 84 participants over 4 months
+5 more records
Product overview1 text field

etectRx is a digital health company offering a platform-plus-products architecture centered on its proprietary eBurst wireless sensor technology. The core product portfolio consists of two main systems: (1) the ID-Cap System, an FDA-cleared digital pill solution for medication adherence monitoring comprising ingestible sensor capsules, wearable readers (necklace and wrist-worn), patient app, and clinician dashboard; and (2) the eBrief System, an intelligent incontinence monitoring solution for senior living facilities consisting of disposable moisture sensor inserts, room readers, and care dashboard. Both systems are powered by the eBurst platform, which enables battery-free, disposable, ingestible, implantable, and wearable sensors for real-time remote health monitoring across patients, providers, and payers.

Product and service4 records
1eBurst Platform
CategoryCore Technology Platform
Description

The foundational wireless sensor technology platform powering all etectRx solutions. eBurst enables battery-free, disposable, ingestible, implantable, and wearable sensors for real-time remote health monitoring across patients, providers, and payers.

2ID-Cap System
CategoryMedication Adherence / Digital Pill System
Description

FDA-cleared digital pill system for medication adherence monitoring. Consists of an ingestible sensor capsule (ID-Capsule), wearable reader (necklace or wrist-worn), patient smartphone app, and clinician dashboard. Activates upon ingestion and transmits adherence data to cloud-based servers for clinical applications including HIV treatment, PrEP, hepatitis C, oncology, and mental health medications.

3eBrief System
CategoryIncontinence Care Monitoring System
Description

Intelligent incontinence monitoring system for senior living and long-term care facilities. Features disposable battery-free moisture sensors (eBrief Insert) embedded in incontinence products, fixed Bluetooth Room Readers installed in resident rooms, and a Care Dashboard providing real-time alerts when briefs need changing and KPI tracking on wetness events. Designed to address staffing shortages and the heavy caregiver burden in senior care.

4ID-Cap Wrist-Worn Reader
CategoryID-Cap Hardware Component
Description

Wearable wrist-worn reader component for the ID-Cap System that detects ingestion signals from the ID-Capsule and transmits data to the patient app and cloud server, providing an alternative to the original necklace form factor.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership13 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-10-21
Description

First New York partnership setting the stage for reimbursement potential. eBrief expands partnership footprint to the Northeast market.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-07-23
Description

Clinical study testing ID-Cap System's technology impact on HIV care. Led by researchers from UCLA and The Lundquist Institute at Harbor-UCLA Medical Center.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-04-07
Description

eBrief Early Adopter Program partnership bringing intelligent incontinence monitoring to two Kansas care communities (Rolling Hills Health and Rehab in Wichita and McPherson Health and Rehab in McPherson). Mission Health manages communities in Georgia, Kansas, Minnesota, Missouri, Tennessee, and Wisconsin.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-03-13
Description

First eBrief Early Adopter Program partnership for adults with intellectual and developmental disabilities. Partnership established in seven residential homes in Rapid City, South Dakota, with plans to expand to five additional homes. Black Hills Works serves almost 600 people with disabilities.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-02-05
Description

eBrief Early Adopter Program partnership for innovative incontinence care solution at EdenHill Communities.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-09-11
Description

eBrief Early Adopter Program partnership for deployment of novel intelligent incontinence care solution at Prairie Lakes Health Campus in Noblesville, Indiana. Trilogy serves over 130 senior living communities throughout Kentucky, Indiana, Ohio, Michigan, and Wisconsin.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-11-13
Description

First industry use of novel eBrief intelligent incontinence monitoring system through a pilot project at Azalea Trace Memory Care Community. The partnership demonstrates the debut application of eBrief for real-time urinary incontinence monitoring in senior living settings.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-10-23
Description

Collaboration on ID-Cap System acceptability study for monitoring medication adherence in individuals with HIV-TB co-infection in South Africa. Mass General Brigham collaborates with University of Cape Town on this research study.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2022-04-29
Description

Integration of AARDEX's adherence analytics software (MEMS) with etectRx's ingestible adherence sensor, creating a comprehensive adherence hardware ecosystem. Based in Liege, Belgium.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-02-26
Description

Partnership to evaluate patient acceptability of ID-Cap System in mental health medication study. Local Health, located in Chicago, recruits patients, dispenses digital pill system, collects data, and publishes survey results. Focus on remote study supported by pharmacy staff.

11Pear Therapeutics
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2021-01-14
Description

Agreement to develop up to two product candidates in the CNS space combining Prescription Digital Therapeutics (PDTs) and adherence sensors. First collaboration exploring use of digital pill solutions with PDTs. Pear is the leader in prescription digital therapeutics with FDA-cleared products including reSET, reSET-O, and Somryst.

etectrx.com
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2020-01-07
Description

QUANTI-TAF clinical study using ID-Cap System to measure adherence to HIV treatment in 180 patients for over 20,000 doses. NIH-sponsored research (NIAID Award Number R01AI145453) led by Principal Investigator Dr. Jose Castillo-Mancilla. One of the largest and longest digital pill studies in HIV treatment history.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2019-01-01
Description

Clinical study to understand how adherence can be increased among populations at risk for HIV infection using ID-Cap System. Partnership with Brigham and Women's Hospital, The Fenway Institute at Fenway Health, and Gilead Sciences.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeOthers
Description

AARDEX is etectRx's existing adherence-analytics integration partner (MEMS / AARDEX Adherence Hardware Ecosystem). Included as a complementary ecosystem player that jointly delivers adherence data to clinical-trial sponsors rather than as a direct competitor.

2Proteus Digital Health
TypeDirect peer
Description

Proteus pioneered FDA-cleared ingestible sensor pills for medication adherence — the closest historical analog to etectRx's ID-Cap System. Both companies built ingestible event-marker technology for clinical trial and commercial adherence use, making Proteus the canonical comparison despite its 2020 bankruptcy.

3AdhereTech
TypeDirect peer
Description

AdhereTech builds connected pill bottles and dispensers that detect medication adherence events and transmit them to clinicians — directly comparable to etectRx's ID-Cap adherence model via a different form factor, targeting overlapping pharmaceutical and patient populations.

TypeDirect peer
Description

AiCure provides AI-driven patient adherence monitoring used in clinical trials for oncology, CNS and other therapeutic areas, overlapping directly with etectRx's ID-Cap deployment in HIV, PrEP and CNS trials.

TypeDirect peer
Description

MedMinder offers connected medication dispensers and adherence systems for seniors, managed-care plans and home-care organizations. Comparable to etectRx in serving senior-living facilities and addressing chronic-condition adherence through remote monitoring.

TypeEmerging player
Description

Pillsy's connected pill-bottle platform tracks dosing and shares adherence data with patients and providers — a narrower, consumer-leaning offering that overlaps with the ID-Cap System's adherence-as-data-service orientation.

TypeBroad incumbent
Description

TENA / Essity is the market-leading incontinence-care brand and is exploring smart incontinence monitoring across senior-living customers. Comparable to eBrief in addressing urinary incontinence in care settings, but as part of a much broader global personal-care portfolio.

TypeEmerging player
Description

CarePredict markets wearable sensors and AI analytics for senior-living communities to track activities of daily living and detect health changes. Comparable to eBrief for senior-living facilities deploying connected sensors for proactive resident monitoring.

TypeBroad incumbent
Description

Vivify Health provides an enterprise remote patient monitoring platform used by health systems and payers across chronic-condition cohorts. Comparable to etectRx's connected-care ambitions across medication adherence and remote monitoring.

10Health Recovery Solutions
TypeEmerging player
Description

Health Recovery Solutions delivers tablet-based RPM kits and clinician dashboards for post-acute and chronic care, intersecting with etectRx's ID-Cap and eBrief clinician-dashboard workflows.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles11 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

etectRx

Digital Health Sensors & Remote Patient Monitoringetectrx.com

etectRx is a digital health company that commercializes its proprietary eBurst wireless sensor platform through two systems: the FDA-cleared ID-Cap ingestible sensor for medication adherence monitoring in clinical trials, and the eBrief disposable moisture sensor system for real-time incontinence care in senior living and long-term care facilities.

What etectRx does

etectRx is a privately held digital health company headquartered in Alachua, Florida, founded in 2009. It commercializes the proprietary eBurst wireless sensor platform, which enables battery-free, disposable, ingestible, implantable, and wearable sensors for real-time remote health monitoring. The company sells two product systems built on this platform: the FDA-cleared ID-Cap System, an ingestible sensor capsule that transmits ingestion events to a wearable reader (necklace or wrist-worn) and onward to a clinician dashboard for medication adherence monitoring; and the eBrief System, a disposable battery-free moisture sensor insert that pairs with fixed room readers and a care dashboard to alert caregivers of urinary incontinence events in real time. The ID-Cap System is deployed primarily through clinical research partnerships with academic medical centers (University of Colorado, Mass General Brigham, UCLA, University of Cape Town) and pharmaceutical collaborators (Gilead, Pear Therapeutics), with applications in HIV, PrEP, hepatitis C, oncology, and CNS adherence studies.

The eBrief System is sold on a subscription license basis to senior living, assisted living, memory care, and skilled nursing facilities via a structured Early Adopter Program, with sequential pilots at operators including Trilogy Health Services, Mission Health Communities, EdenHill Communities, Mozaic, Black Hills Works, and The Village at Gainesville. Revenue is generated through eBrief subscription contracts (multi-year), ID-Cap hardware and digital pill sales, and clinical research study participation. The company holds 15 issued US patents, maintains HIPAA compliance, and has produced 15+ IRB-validated clinical studies including the NIH-sponsored QUANTI-TAF HIV adherence study demonstrating 95% cumulative adherence across 84 participants over four months.

etectRx firmographics

Firmographics
Name
etectRx
Legal name
etectRx LLC
Website
https://etectrx.com
Company type
Private
Founded year
2009
Operating status
Operating
Headcount range
11–50 employees
Short description
etectRx is a digital health company that commercializes its proprietary eBurst wireless sensor platform through two systems: the FDA-cleared ID-Cap ingestible sensor for medication adherence monitoring in clinical trials, and the eBrief disposable moisture sensor system for real-time incontinence care in senior living and long-term care facilities.
Ownership category
akta.pro rank

etectRx industry classification

Industry
Product category
Digital Health Sensors & Remote Patient Monitoring
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHLACAPAH
Medication Adherence & Smart Drug Delivery (Connected Inhalers, Pens, Pill Dispensers)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLACAPAB
Connected Medical Devices & Wearables (Sensors, Patches, Implantables)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHSABAJAI
Smart Home & Assistive Technology Installation for Aging-in-Place
Home & Personal Services/Elder Care & In-Home Care Services/Home Safety Assessment & Aging-in-Place Modifications

Keywords

  • Digital health sensors
  • Medication adherence monitoring
  • Ingestible sensor technology
  • Remote patient monitoring
  • Incontinence care systems

Where etectRx is headquartered

Location

Headquarters

HQ city
Gainesville
HQ country
United States
HQ region
North America

Offices1 record

Markets served

etectRx business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations

Revenue model

  1. eBrief System Subscription: The eBrief Intelligent Incontinence Monitoring System is offered through subscription license for senior living, assisted living, memory care, skilled nursing, and related healthcare facilities. The system includes sensors (disposable inserts), readers (fixed devices), monitoring tablets, and dashboard access.
  2. ID-Cap System (Digital Pills): The FDA-cleared ID-Cap System generates revenue through the sale of digital pills (ingestible sensors), wearable readers, patient apps, and clinician dashboards. Revenue derived from clinical trials, healthcare providers, and pharmaceutical partnerships.
  3. Clinical Research Partnerships: Collaborations with academic medical centers, hospitals, and research institutions for medication adherence studies using the ID-Cap System. These partnerships support clinical validation and generate revenue through study participation.

Pricing tiers

ModelBillingPrice
SubscriptionMulti-year contracteBrief System subscription for healthcare facilities

Go-to-market motion2 records

Distribution channels4 records

Marketing channels9 records

etectRx product offering

Product offering

Core offering

etectRx develops and commercializes digital health monitoring systems based on its proprietary eBurst wireless sensor technology. Its primary offerings are the FDA-cleared ID-Cap System for medication adherence (ingestible sensor + wearable reader + apps + clinician dashboard) and the eBrief Intelligent Incontinence Monitoring System (disposable battery-free moisture sensors + room readers + care dashboard) sold to senior living, assisted living, and long-term care facilities.

Product overview

etectRx is a digital health company offering a platform-plus-products architecture centered on its proprietary eBurst wireless sensor technology. The core product portfolio consists of two main systems: (1) the ID-Cap System, an FDA-cleared digital pill solution for medication adherence monitoring comprising ingestible sensor capsules, wearable readers (necklace and wrist-worn), patient app, and clinician dashboard; and (2) the eBrief System, an intelligent incontinence monitoring solution for senior living facilities consisting of disposable moisture sensor inserts, room readers, and care dashboard. Both systems are powered by the eBurst platform, which enables battery-free, disposable, ingestible, implantable, and wearable sensors for real-time remote health monitoring across patients, providers, and payers.

Differentiator

Problem solved

Functional benefit

Brands

  • eBurst: Novel wireless sensor technology platform enabling real-time remote monitoring for ingestible, implantable, and wearable sensors.
  • eBrief
  • ID-Cap

Products and services

  • eBurst Platform The foundational wireless sensor technology platform powering all etectRx solutions. eBurst enables battery-free, disposable, ingestible, implantable, and wearable sensors for real-time remote health monitoring across patients, providers, and payers.
  • ID-Cap System FDA-cleared digital pill system for medication adherence monitoring. Consists of an ingestible sensor capsule (ID-Capsule), wearable reader (necklace or wrist-worn), patient smartphone app, and clinician dashboard. Activates upon ingestion and transmits adherence data to cloud-based servers for clinical applications including HIV treatment, PrEP, hepatitis C, oncology, and mental health medications.
  • eBrief System Intelligent incontinence monitoring system for senior living and long-term care facilities. Features disposable battery-free moisture sensors (eBrief Insert) embedded in incontinence products, fixed Bluetooth Room Readers installed in resident rooms, and a Care Dashboard providing real-time alerts when briefs need changing and KPI tracking on wetness events. Designed to address staffing shortages and the heavy caregiver burden in senior care.
  • ID-Cap Wrist-Worn Reader Wearable wrist-worn reader component for the ID-Cap System that detects ingestion signals from the ID-Capsule and transmits data to the patient app and cloud server, providing an alternative to the original necklace form factor.

Quantifiable outcome

  • 95% cumulative adherence rate in QUANTI-TAF HIV treatment study with 84 participants over 4 months
  • +5 more outcomes

Companies that use etectRx

Customer profile

Named customers10 records

Segments4 records

Ideal customer profiles3 records

etectRx technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

Feature5 records

etectRx partnerships and signals

Strategic signal

Partnerships

13 partnerships are on record, tiered core and flagship.

  • MozaiccoreStrategic or Co-development Partner · 21 October 2025First New York partnership setting the stage for reimbursement potential. eBrief expands partnership footprint to the Northeast market.
  • UCLA / The Lundquist Institute at Harbor-UCLA Medical CentercoreStrategic or Co-development Partner · 23 July 2025Clinical study testing ID-Cap System's technology impact on HIV care. Led by researchers from UCLA and The Lundquist Institute at Harbor-UCLA Medical Center.
  • Mission Health CommunitiescoreStrategic or Co-development Partner · 7 April 2025eBrief Early Adopter Program partnership bringing intelligent incontinence monitoring to two Kansas care communities (Rolling Hills Health and Rehab in Wichita and McPherson Health and Rehab in McPherson). Mission Health manages communities in Georgia, Kansas, Minnesota, Missouri, Tennessee, and Wisconsin.
  • Black Hills WorkscoreStrategic or Co-development Partner · 13 March 2025First eBrief Early Adopter Program partnership for adults with intellectual and developmental disabilities. Partnership established in seven residential homes in Rapid City, South Dakota, with plans to expand to five additional homes. Black Hills Works serves almost 600 people with disabilities.
  • EdenHill CommunitiescoreStrategic or Co-development Partner · 5 February 2025eBrief Early Adopter Program partnership for innovative incontinence care solution at EdenHill Communities.
  • Trilogy Health ServicescoreStrategic or Co-development Partner · 11 September 2024eBrief Early Adopter Program partnership for deployment of novel intelligent incontinence care solution at Prairie Lakes Health Campus in Noblesville, Indiana. Trilogy serves over 130 senior living communities throughout Kentucky, Indiana, Ohio, Michigan, and Wisconsin.
  • The Village at GainesvillecoreStrategic or Co-development Partner · 13 November 2023First industry use of novel eBrief intelligent incontinence monitoring system through a pilot project at Azalea Trace Memory Care Community. The partnership demonstrates the debut application of eBrief for real-time urinary incontinence monitoring in senior living settings.
  • University of Cape Town / Mass General BrighamcoreStrategic or Co-development Partner · 23 October 2023Collaboration on ID-Cap System acceptability study for monitoring medication adherence in individuals with HIV-TB co-infection in South Africa. Mass General Brigham collaborates with University of Cape Town on this research study.
  • AARDEX GroupcoreTechnology or Integration · 29 April 2022Integration of AARDEX's adherence analytics software (MEMS) with etectRx's ingestible adherence sensor, creating a comprehensive adherence hardware ecosystem. Based in Liege, Belgium.
  • Local Health Inc. (OneroRx)coreStrategic or Co-development Partner · 26 February 2021Partnership to evaluate patient acceptability of ID-Cap System in mental health medication study. Local Health, located in Chicago, recruits patients, dispenses digital pill system, collects data, and publishes survey results. Focus on remote study supported by pharmacy staff.
  • Pear TherapeuticsflagshipStrategic or Co-development Partner · 14 January 2021Agreement to develop up to two product candidates in the CNS space combining Prescription Digital Therapeutics (PDTs) and adherence sensors. First collaboration exploring use of digital pill solutions with PDTs. Pear is the leader in prescription digital therapeutics with FDA-cleared products including reSET, reSET-O, and Somryst.
  • University of Colorado Anschutz Medical Campus / NIHflagshipStrategic or Co-development Partner · 7 January 2020QUANTI-TAF clinical study using ID-Cap System to measure adherence to HIV treatment in 180 patients for over 20,000 doses. NIH-sponsored research (NIAID Award Number R01AI145453) led by Principal Investigator Dr. Jose Castillo-Mancilla. One of the largest and longest digital pill studies in HIV treatment history.
  • Brigham and Women's Hospital / The Fenway Institute / Gilead SciencescoreStrategic or Co-development Partner · 1 January 2019Clinical study to understand how adherence can be increased among populations at risk for HIV infection using ID-Cap System. Partnership with Brigham and Women's Hospital, The Fenway Institute at Fenway Health, and Gilead Sciences.

Scale indicators6 records

Recent moves6 records

Expansion highlights7 records

etectRx competitors and assessment

Company assessment

Others

  • AARDEX Group: AARDEX is etectRx's existing adherence-analytics integration partner (MEMS / AARDEX Adherence Hardware Ecosystem). Included as a complementary ecosystem player that jointly delivers adherence data to clinical-trial sponsors rather than as a direct competitor.

Direct peers

  • Proteus Digital Health: Proteus pioneered FDA-cleared ingestible sensor pills for medication adherence — the closest historical analog to etectRx's ID-Cap System. Both companies built ingestible event-marker technology for clinical trial and commercial adherence use, making Proteus the canonical comparison despite its 2020 bankruptcy.
  • AdhereTech: AdhereTech builds connected pill bottles and dispensers that detect medication adherence events and transmit them to clinicians — directly comparable to etectRx's ID-Cap adherence model via a different form factor, targeting overlapping pharmaceutical and patient populations.
  • AiCure: AiCure provides AI-driven patient adherence monitoring used in clinical trials for oncology, CNS and other therapeutic areas, overlapping directly with etectRx's ID-Cap deployment in HIV, PrEP and CNS trials.
  • MedMinder: MedMinder offers connected medication dispensers and adherence systems for seniors, managed-care plans and home-care organizations. Comparable to etectRx in serving senior-living facilities and addressing chronic-condition adherence through remote monitoring.

Emerging players

  • Pillsy (Cogni+): Pillsy's connected pill-bottle platform tracks dosing and shares adherence data with patients and providers — a narrower, consumer-leaning offering that overlaps with the ID-Cap System's adherence-as-data-service orientation.
  • CarePredict: CarePredict markets wearable sensors and AI analytics for senior-living communities to track activities of daily living and detect health changes. Comparable to eBrief for senior-living facilities deploying connected sensors for proactive resident monitoring.
  • Health Recovery Solutions: Health Recovery Solutions delivers tablet-based RPM kits and clinician dashboards for post-acute and chronic care, intersecting with etectRx's ID-Cap and eBrief clinician-dashboard workflows.

Broad incumbents

  • TENA (Essity): TENA / Essity is the market-leading incontinence-care brand and is exploring smart incontinence monitoring across senior-living customers. Comparable to eBrief in addressing urinary incontinence in care settings, but as part of a much broader global personal-care portfolio.
  • Vivify Health: Vivify Health provides an enterprise remote patient monitoring platform used by health systems and payers across chronic-condition cohorts. Comparable to etectRx's connected-care ambitions across medication adherence and remote monitoring.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

etectRx social profiles

Digital presence

etectRx compliance and trust

Trust signal

Compliance2 records

etectRx financial estimates

Financial estimate

Revenue estimate

Valuation estimate

etectRx leadership team

Management profile

Number of profiles

Profiles11 records

etectRx funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

etectRx M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about etectRx

What does etectRx do?

etectRx develops and commercializes digital health monitoring systems based on its proprietary eBurst wireless sensor technology. Its primary offerings are the FDA-cleared ID-Cap System for medication adherence (ingestible sensor + wearable reader + apps + clinician dashboard) and the eBrief Intelligent Incontinence Monitoring System (disposable battery-free moisture sensors + room readers + care dashboard) sold to senior living, assisted living, and long-term care facilities.

Is etectRx a public or private company?

etectRx is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was etectRx founded?

etectRx was founded in 2009. It employs 11 to 50 people.

Where is etectRx based?

etectRx is headquartered in Gainesville, United States, in the North America region.

How does etectRx make money?

Three revenue lines are on record. eBrief System Subscription is the primary driver. The others are ID-Cap System (Digital Pills) and clinical Research Partnerships.

Who are etectRx's main competitors?

AARDEX Group is listed as an others. Direct peers are Proteus Digital Health, AdhereTech, AiCure and MedMinder. Emerging players are Pillsy (Cogni+), CarePredict and Health Recovery Solutions. Broad incumbents are TENA (Essity) and Vivify Health.

Does etectRx have an API?

No public API is recorded for etectRx.

What industry is etectRx in?

etectRx's product category is Digital Health Sensors & Remote Patient Monitoring. Its primary akta.pro industry code is HLACAPAH, Medication Adherence & Smart Drug Delivery (Connected Inhalers, Pens, Pill Dispensers), with a secondary code of HLACAPAB, Connected Medical Devices & Wearables (Sensors, Patches, Implantables). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Market Report AnalyticsConsumer Trends Driving Medication Adherence Monitoring System Market GrowthThe global medication adherence monitoring system market is projected to grow from an estimated $2 billion in 2025 to approximately $7 billion by 2033, driven by rising chronic disease prevalence and technological advancements. Key industry players Aardex Group and etectRx are actively shaping the competitive landscape through product innovation and strategic developments, such as FDA approvals and new sensor launches.National Center for Biotechnology InformationNIA Small Business Showcase: etectRxetectRx, a digital health sensor company, offers the ID-Cap system for medication adherence monitoring, with FDA clearance in 2019. The company has raised $20 million in grants and private equity and plans to raise another $20 million. It is expanding into incontinence monitoring and new health areas.GlobeNewswireSmart Pills Market Industry Trend Analysis, and Forecast 2025-2034, with Profiles of ANX Robotica, Bodycap, CapsoVision, Check-Cap, etectRx, Intromedic, Medtronic, Otsuka, Olympus and RFThe smart pills market was valued at USD 1.2 billion in 2024 and is projected to reach USD 3.4 billion by 2034, a CAGR of 11.6%. The stomach segment held 44.1% of the market in 2024, and North America led with USD 455.5 million. Growth is driven by gastrointestinal disorders and demand for non-invasive diagnostics.Archive Market ResearchMedication Adherence Monitoring System 2025 to Grow at XX CAGR with XXX million Market Size: Analysis and Forecasts 2033Archive Market Research published a market intelligence report on the global Medication Adherence Monitoring System market, covering applications, device types, and regions through 2033. The report cites a base year of 2024, North American dominance, and Asia Pacific as the fastest-growing region, with players including Aardex Group, etectRx, Bayer, Pfizer and Novartis.JMIR PreprintsA Novel Digital Pill System for Medication Adherence Measurement and Reporting: Usability Validation StudyA human factors validation study tested the ID-Cap System, a digital ingestible pill tracker from etectRx, with 17 patients at Tensentric in Boulder, Colorado. Participants aged 27-74 completed 97.5% of 201 use scenarios, with 75.1% error-free, and no new safety risks were found. The FDA granted the device 510(k) clearance in December 2019.PR NewswireetectRx Targets Mental Health Field In Partnership With Local Health PharmacyDigital health company etectRx announced a signed letter of intent for a partnership with Local Health, Inc., a subsidiary of OneroRx, to evaluate patient acceptability of etectRx's FDA-cleared ID-Cap digital pill system. The study, scheduled to begin in summer 2021, will focus on mental health medication, with Local Health recruiting patients, dispensing the system, collecting data, and publishing survey results. etectRx reports its ID-Cap System has 98% accuracy and has recorded over 5,900 ingestions across 15 IRB clinical research studies, positioning the company to expand use cases following Proteus Digital Health's acquisition by Otsuka Pharmaceutical in 2020.PR NewswireGlobal Medication Adherence Markets (2021 to 2025) - Key Market Drivers and RestraintsResearchAndMarkets.com announced the publication of a comprehensive market research report covering global medication adherence systems and technologies from 2021 to 2025, providing analysis of both hardware-based products (smart pill bottles, automated dispensers, wearable sensors) and software-based applications (mobile apps, web portals, cloud databases). The report examines market drivers including aging populations, rising chronic disease prevalence, and smartphone adoption, alongside market restraints, competitive landscape, and strategic acquisitions among industry participants. Key companies profiled in the report include ActualMeds Corp., etectRx, Health Net Inc., MedaCheck, Omnicell Inc., and Philips Healthcare, spanning the medication adherence technology ecosystem.PR NewswireetectRx Announces Agreement to Advance Digital Sensors for Medication Adherence in Combination with Prescription Digital TherapeuticsDigital health company etectRx announced an agreement with Pear Therapeutics to develop up to two product candidates combining Prescription Digital Therapeutics (PDTs) with adherence sensors, marking the first collaboration of its kind to explore digital pill solutions with PDTs. The partnership will leverage etectRx's FDA-cleared ID-Cap System alongside Pear's digital therapeutic products to address medication adherence in the mental health field. Pear's CEO indicated that optimized medication dosing presents a treatment lever for PDTs and creates opportunities for drug/software combination products.PR NewswireetectRx™ Announces New CEOetectRx, a privately held digital health company, announced the appointment of Valerie Sullivan as its new president and CEO, succeeding Harry J. Travis who will remain on the board of directors. The company received FDA clearance for its ingestible event marker, the ID-Cap System, in late 2019 and is currently in dialogue with pharmaceutical companies for commercialization. Sullivan brings extensive experience in pharma, digital health, and pharma services, having previously led patient access solutions and patient service operations at other companies.